Page last updated: 2024-09-05

melagatran and Shock, Septic

melagatran has been researched along with Shock, Septic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eriksson, M; Larsson, A; Mattsson, C; Saldeen, T	1
Basu, S; Eriksson, M; Eriksson, O; Kiiski, R; Larsson, A; Mattsson, C; Nordgren, A	1

Reviews

1 review(s) available for melagatran and Shock, Septic

Article	Year
Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:5 Topics: Animals; Azetidines; Benzylamines; Glycine; Humans; Shock, Septic; Thrombin	2000

Other Studies

1 other study(ies) available for melagatran and Shock, Septic

Article	Year
Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pig. Thrombosis and haemostasis, 1998, Volume: 80, Issue:6 Topics: Animals; Azetidines; Benzylamines; Blood Coagulation; Creatinine; Diuresis; Drug Evaluation, Preclinical; Endotoxemia; Female; Fibrinolytic Agents; Glycine; Half-Life; Hemodynamics; Kidney; Male; Oxygen Consumption; Partial Thromboplastin Time; Platelet Count; Shock, Septic; Swine; Thrombin	1998

Article

Year

Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pig.

Thrombosis and haemostasis, 1998, Volume: 80, Issue:6

Topics: Animals; Azetidines; Benzylamines; Blood Coagulation; Creatinine; Diuresis; Drug Evaluation, Preclinical; Endotoxemia; Female; Fibrinolytic Agents; Glycine; Half-Life; Hemodynamics; Kidney; Male; Oxygen Consumption; Partial Thromboplastin Time; Platelet Count; Shock, Septic; Swine; Thrombin

1998